Stephen J. Lee, M.D.

  • Assistant Clinical Professor, Division of Gynecologic Oncology, Department of Surgery
  • Gynecologic Oncology Surgeon

Stephen J. Lee, M.D.

Clinical Specialties
  • Gynecologic Oncology
Areas of Expertise
  • Cervical Cancer
  • Heated Intraperitoneal Chemotherapy (HIPEC)
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
  • Robotic Surgery
Other Languages Spoken
  • Korean
  • Spanish

Stephen J. Lee, M.D., is a gynecologic oncologist specializing in advanced cytoreductive procedures for ovarian cancer, which can significantly improve the survival outcome for patients. He is also an expert in robotic-assisted (minimally invasive) surgery for uterine and cervical cancers, which can reduce scarring, pain and recovery time.

Dr. Lee received his medical doctorate from the Feinberg School of Medicine of Northwestern University in Chicago and completed an internship in general surgery at Rush University Medical Center, also in Chicago. He continued his postgraduate training at the Albert Einstein College of Medicine in Bronx, New York, in obstetrics and gynecology, and completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center. He has written more than 20 publications and has been invited to discuss his work nationally and internationally.

  • 2015 to present - Assistant Clinical Professor, Division of Gynecologic Oncology, Department of Surgery, City of Hope, Duarte, CA
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
  • Cervical Cancer
  • Gynecological Cancers


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010

Get Directions

Phone :  626-256-4673

South Pasadena

City of Hope South Pasadena, 209 Fair Oaks Ave., South Pasadena, CA, 91030

Get Directions

Phone :  877-998-7546


  • 2004 - Northwestern University, Feinberg School of Medicine, Chicago, IL, M.D.
  • 1999 - Northwestern University, Evanston, IL, B.A., Biological Sciences (Physiology) and Economics, Cum Laude


  • 2011 to 2015 - Gynecological Service Fellowship, Memorial Sloan Kettering Cancer Center, New York, NY,


  • 2007 to 2011 - Albert Einstein College of Medicine, Montefiore Medical Center, Department of Obstetrics & Gynecology and Women's Health, Bronx, NY


  • 2004 to 2005 - General Surgery Internship, Rush University Medical Center, Chicago, IL,

Suidan RS, St Clair CM, Lee SJ, Barlin JN, Long Roche KC, Tanner EJ, Sonoda Y, Barakat RR, Zivanovic O,Chi DS. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecol Oncol. 2014 Sep;134(3):468-72

Lee SJ, Calderon B, Gardner GJ, Mays A, Nolan S, Sonoda Y, Barakat RR, Leitao MM Jr. The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications. Gynecol Oncol. 2014 Jun;133(3):552-5

Leitao MM Jr, Bartashnik A, Wagner I, Lee SJ, Caroline A, Hoskins WJ, Thaler HT, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell EL, Barakat RR, Gardner GJ. Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers. Obstet Gynecol. 2014 May;123(5):1031-7

Seagle BL, Falter KJ 2nd, Lee SJ, Frimer M, Samuelson R, Shahabi S. Mullerian adenosarcoma of the cervix: report of two large tumors with sarcomatous overgrowth or heterologous elements. Gynecol Oncol Case Rep. 2014 May 5;9:7-10

Sandadi S, Gadzinski JA, Lee S, Chi DS, Sonoda Y, Jewell EL, Brown CL, Gardner GJ, Barakat RR, Leitao MM Jr. Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy. Gynecol Oncol. 2014 Jan;132(1):102-6

Sandadi S, Lee S, Walter A, Gardner GJ, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell E, Parameswaran R, Barakat RR, Leitao MM Jr. Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol. 2012 Nov;120(5):1077-83

Einstein MH, Klobocista M, Hou JY, Lee S, Mutyala S, Mehta K, Reimers LL, Kuo DYS, Huang GS, Goldberg GL. Phase II Trial of Adjuvant Pelvic Radiation "Sandwiched" Between Ifosfamide or Ifosfamide plus Cisplatin in Women with Uterine Carcinosarcoma. Gynecol Oncol. 2012 Jan;124(1):26-30

Gupta D, Gunter MJ, Yang K, Lee S, Zuckerwise L, Chen L, Goldberg GL, Huang GS: Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma. International Journal ofGynecological Cancer. 2011;21(3):529-534

  • Society of Gynecologic Oncology
  • American College of Obstetricians and Gynecologists
  • American Medical Association
Back To Top